Although this work reveal the potential of DNMT1 as therapeutic target of ESCC, further investigation is needed to unveil the mystery about utilizing DNMT1 to develop tumor-oriented reagent for WSCC therapy. This evidence concerns the gene DNMT1 and esophageal squamous cell carcinoma.